"Greene describes the relationship between advances in treatment, the incentives of manufacturers, and the effect on the public of increased attention to prevention... The risk-benefit trade-offs of the quantitative approach are complex, and Greene's historical revelations are timely." -- New England Journal of Medicine
"One of the best, and most significant, books published recently on the development of medical practice and the pharmaceutical industry in the U.S. in the second half of the twentieth century." -- Social History of Medicine
"Greene focuses on the question of how public health priorities became closely aligned with the pharmaceutical industry's marketing practices... [and] offers a nuanced descriptionof the development of 'therapeutics of risk reduction' with multiple lines of influence, subtle power shifts, and gains and losses for patients and physicians." -- Chemical Heritage
"A gripping story... Greene warns us in his superb book that things are not always as they are claimed." -- Yale Journal for Humanities in Medicine
Jeremy A. Greene is a fellow in the Department of Social Medicine at Harvard Medical School and a resident in the Department of Medicine at Brigham and Women's Hospital.
Or split into 4x interest-free payments of 25% on orders over R50
Learn more
"Greene describes the relationship between advances in treatment, the incentives of manufacturers, and the effect on the public of increased attention to prevention... The risk-benefit trade-offs of the quantitative approach are complex, and Greene's historical revelations are timely." -- New England Journal of Medicine
"One of the best, and most significant, books published recently on the development of medical practice and the pharmaceutical industry in the U.S. in the second half of the twentieth century." -- Social History of Medicine
"Greene focuses on the question of how public health priorities became closely aligned with the pharmaceutical industry's marketing practices... [and] offers a nuanced descriptionof the development of 'therapeutics of risk reduction' with multiple lines of influence, subtle power shifts, and gains and losses for patients and physicians." -- Chemical Heritage
"A gripping story... Greene warns us in his superb book that things are not always as they are claimed." -- Yale Journal for Humanities in Medicine
Jeremy A. Greene is a fellow in the Department of Social Medicine at Harvard Medical School and a resident in the Department of Medicine at Brigham and Women's Hospital.
Imprint | Johns Hopkins University Press |
Country of origin | United States |
Release date | February 2009 |
Availability | Expected to ship within 12 - 17 working days |
First published | 2007 |
Authors | Jeremy A. Greene |
Dimensions | 229 x 152 x 22mm (L x W x T) |
Format | Paperback |
Pages | 336 |
ISBN-13 | 978-0-8018-9100-7 |
Barcode | 9780801891007 |
Categories | |
LSN | 0-8018-9100-0 |